0001231919-23-000037.txt : 20230601
0001231919-23-000037.hdr.sgml : 20230601
20230601164001
ACCESSION NUMBER: 0001231919-23-000037
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20230601
DATE AS OF CHANGE: 20230601
EFFECTIVENESS DATE: 20230601
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: X4 Pharmaceuticals, Inc
CENTRAL INDEX KEY: 0001501697
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 273181608
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-483142
FILM NUMBER: 23985291
BUSINESS ADDRESS:
STREET 1: 61 NORTH BEACON STREET
STREET 2: 4TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02134
BUSINESS PHONE: 857-529-8300
MAIL ADDRESS:
STREET 1: 61 NORTH BEACON STREET
STREET 2: 4TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02134
FORMER COMPANY:
FORMER CONFORMED NAME: Arsanis, Inc.
DATE OF NAME CHANGE: 20100920
D
1
primary_doc.xml
X0708
D
LIVE
0001501697
X4 Pharmaceuticals, Inc
61 NORTH BEACON STREET
4TH FLOOR
BOSTON
MA
MASSACHUSETTS
02134
857-529-8300
DELAWARE
Arsanis, Inc.
Corporation
true
Paula
Ragan
61 North Beacon Street
4th Floor
Boston
MA
MASSACHUSETTS
02134
Executive Officer
Director
Adam
Mostafa
61 North Beacon Street
4th Floor
Boston
MA
MASSACHUSETTS
02134
Executive Officer
Mary
DiBiase
61 North Beacon Street
4th Floor
Boston
MA
MASSACHUSETTS
02134
Executive Officer
Mark
Baldry
61 North Beacon Street
4th Floor
Boston
MA
MASSACHUSETTS
02134
Executive Officer
Arthur
Taveras
61 North Beacon Street
4th Floor
Boston
MA
MASSACHUSETTS
02134
Executive Officer
Murray
Stewart
61 North Beacon Street
4th Floor
Boston
MA
MASSACHUSETTS
02134
Executive Officer
Director
William
Aliski
61 North Beacon Street
4th Floor
Boston
MA
MASSACHUSETTS
02134
Director
Alison
Lawton
61 North Beacon Street
4th Floor
Boston
MA
MASSACHUSETTS
02134
Director
Gary
Bridger
61 North Beacon Street
4th Floor
Boston
MA
MASSACHUSETTS
02134
Director
Francoise
de Craecker
61 North Beacon Street
4th Floor
Boston
MA
MASSACHUSETTS
02134
Director
David
McGirr
61 North Beacon Street
4th Floor
Boston
MA
MASSACHUSETTS
02134
Director
Michael
Wyzga
61 North Beacon Street
4th Floor
Boston
MA
MASSACHUSETTS
02134
Director
Biotechnology
Decline to Disclose
- 06b
false
2023-05-18
false
true
true
true
false
0
Stifel, Nicolaus & Company, Inc.
793
None
None
One South Street, 15th Floor
Baltimore
MD
MARYLAND
21202
CT
CONNECTICUT
DE
DELAWARE
FL
FLORIDA
MD
MARYLAND
MA
MASSACHUSETTS
NY
NEW YORK
OR
OREGON
false
Piper Sandler & Co.
665
None
None
800 Nicollet Mall, Suite 900
Minneapolis
MN
MINNESOTA
55402
CT
CONNECTICUT
DE
DELAWARE
FL
FLORIDA
MD
MARYLAND
MA
MASSACHUSETTS
NY
NEW YORK
OR
OREGON
false
Cantor Fitzgerald & Co.
134
None
None
c/o Cantor Fitzgerald Investors, LLC
110 E. 59th Street
New York
NY
NEW YORK
10022
CT
CONNECTICUT
DE
DELAWARE
FL
FLORIDA
MD
MARYLAND
MA
MASSACHUSETTS
NY
NEW YORK
OR
OREGON
false
65023725
65015462
8263
"Total Offering Amount" includes amounts receivable by the Issuer upon the exercise of certain warrants to purchase the Issuer's Common Stock (assuming no cashless exercise).
false
22
4000000
true
0
0
false
X4 Pharmaceuticals, Inc
/s/ Adam Mostafa
Adam Mostafa
Chief Financial Officer
2023-06-01